Our website uses cookies, which are small text files that are intended to make the site better for you to use, and that help us understand how people interact with our content so that we can make it better.

    You can find out more details about Clue's approach to privacy by reading our Privacy Policy

    These cookies are necessary for the website to function and cannot be switched off.

    They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in, or filling in forms. These cookies do not store any personally identifiable information.

    The Clue website uses third-party analysis and tracking services to track the performance of our services, understand how you use our services, and offer you an improved experience.

    You may withdraw your consent to this processing of your data at any time. One way to so is by generally disabling cookies on your device (which will also affect your other online activities). Or you can disable cookies specifically for this website by switching the toggle to 'Off'.

    You can read more about how Clue handles and thinks about data in the following blog posts written by our founder and CEO, Ida Tin.

    The journey of a single data pointThe journey of a single data point, Part II: The underworld of digital advertisingThe journey of a single data point, Part III: About the selling of health data

Your Privacy

Our website uses cookies, which are small text files that are intended to make the site better for you to use, and that help us understand how people interact with our content so that we can make it better.

You can find out more details about Clue's approach to privacy by reading our Privacy Policy

Your Privacy

We use cookies on our website to analyze how people use it and improve the experience.

You can read more about how we use cookies in our Privacy Policy, or manage your preferences here.

Technology

The rise of a new category: Femtech

by Ida Tin, CEO of Clue
  • Share this article on Twitter
  • Share this article on Facebook
  • Share this article with WhatsApp

In 2009, I sat with an old phone in my hand — the kind with a small screen and actual buttons. The iPhone had launched, but it was not in my life yet. In my other hand, I held a small device collecting my temperature every morning to help me figure out which days I was fertile. I urgently wanted to merge those two devices; to be able to look at my phone and know what was going on in my body, rather than enduring the tedious experience of manually transferring data from the temperature device into a spreadsheet, just so I could use it. That lead me to start Clue and with that I became part of what — 7 years later — I recognize as an entirely new category of business.

In 2016 the world now has an explosion of apps which help track menstrual cycles, resulting in an unprecedented amount of data for researchers. The menstrual cycle is going through a technological revolution, alongside a cultural revolution, allowing what was once taboo to emerge, liberated.

Add to that an enormous range of technology innovations such as temperature patches, insertable devices, wristbands, clip-ons, smart jewelry, DNA testing related to fertility and many other devices and data analytics helping people figure out their female health. What emerges is a new and huge category addressing female health needs through technology: femtech.

When looking at companies that deliver software, diagnostics, services and products targeting women’s health needs, I see a fluffiness and confusion of terms that struggles to describe the individual product — and even more so shows an obvious lack of a collective description of this emerging mega category.

We know the term Femcare, which covers menstrual products such as pads, tampons, etc. — alone that is a $30 billion market. But what about the new menstrual product delivery app and subscription service? Is Femcare the right category for that service? Or the $18 billion market for contraceptives, which is being partly re-invented and partly enhanced through apps that help women use natural family planning or remind them to take their hormonal birth control. There’s the $14 billion fertility market and a $4 billion menopause market; the first already changing and the second still hugely underserved. All of those markets will be altered and shaken by digital.They will be linked and integrated through data with new services delivered through APIs from Apple HealthKit, Google Fit, Clue and others. This is femtech and it includes all the many players that bring technology to female health in a myriad of ways.

This will be a massive category. It’s growing faster every day. I believe venture capitalists will list femtech as one of their areas of interest. There will be femtech conferences. Femtech will not be a term referring to “women in technology” but rather as an expanding category of technology that serves the vast opportunities that exist for female health.

You might also like to read

Popular Articles